$OMDA

Cook Steven L. sold $7K of OMDA

Cook Steven L. (Chief Financial Officer) sold 300 shares of Omada Health, Inc. (OMDA) at $22.00 on 2026-06-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:35 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings, but it does not introduce new company fundamentals or policy changes.

02

Market read

Traders may note the insider sale, but the 10b5-1 designation and small transaction size reduce expected market impact.

03

What to watch

The dollar amount is relatively small and the filing does not include any new operational or financial guidance, so traders may treat it as routine compliance rather than a catalyst.

Relevance 2/10Novelty 3/10Timing: filed July 2, 2026 after-hours/late session disclosure

Background

The article is an SEC Form 4 insider transaction disclosure for Omada Health, Inc. (OMDA).

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Steven L. Cook filed a Form 4 open-market sale of 300 shares at $22.00 on June 30 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move based solely on this Form 4 sale.

Evidence & confidence

The filing specifies an open-market sale and confirms a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can still coincide with private information, but the explicit 10b5-1 pre-arrangement makes that interpretation less compelling.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Steven L. Cook

    Chief Financial Officer who sold 300 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch